# Expanding the Anatomical Distribution of PRRX1::KMT2D Fusion Mesenchymal Neoplasms: A Rare Mediastinal Case Report

**Authors:** Weixiang Zhong, Yu Deng, Ke Sun

PMC · DOI: 10.1002/cnr2.70516 · Cancer Reports · 2026-03-08

## TL;DR

A rare tumor with a PRRX1::KMT2D fusion was found in the mediastinum, expanding its known location and highlighting the need for advanced diagnostic methods.

## Contribution

This is the first reported case of a PRRX1::KMT2D fusion tumor in the mediastinum.

## Key findings

- The tumor was successfully resected and confirmed via pathology and RNA sequencing.
- No recurrence was observed after 18 months of follow-up.
- The case expands the anatomical distribution of PRRX1::KMT2D fusion neoplasms.

## Abstract

PRRX1‐rearranged mesenchymal neoplasms are rare soft tissue tumors with a predilection for the superficial subcutaneous tissue. The PRRX1::KMT2D fusion variant is exceptionally rare, with only three previously reported cases, all of which were located in the intermuscular regions. However, its occurrence in deep visceral sites has not been documented.

A 62‐year‐old woman was admitted after a routine physical examination revealed a space‐occupying lesion in the left thoracic cavity. Contrast‐enhanced CT showed a mixed‐density mass (10.4 × 8.1 × 3.8 cm) at the left cardiophrenic angle. The patient underwent complete thoracoscopic resection. Intraoperative frozen sections suggested a spindle cell tumor. Postoperative pathology, immunohistochemistry, and targeted RNA sequencing identified a PRRX1::KMT2D fusion mesenchymal neoplasm. At 18‐month follow‐up, no recurrence or progression was observed.

This is the first reported case of a PRRX1::KMT2D fusion mesenchymal neoplasm arising in the mediastinum, which expands the anatomical spectrum of this emerging entity. Our findings underscore the importance of integrating morphological, immunohistochemical, and molecular approaches for accurate diagnosis, particularly in deep‐seated and unusual locations.

## Linked entities

- **Genes:** PRRX1 (paired related homeobox 1) [NCBI Gene 5396], KMT2D (lysine methyltransferase 2D) [NCBI Gene 8085]

## Full-text entities

- **Genes:** PRRX1 (paired related homeobox 1) [NCBI Gene 5396] {aka AGOTC, PHOX1, PMX1, PRX-1, PRX1}, KMT2D (lysine methyltransferase 2D) [NCBI Gene 8085] {aka AAD10, ALR, BCAHH, CAGL114, KABUK1, KMS}, SOX10 (SRY-box transcription factor 10) [NCBI Gene 481258], CD34 (CD34 molecule) [NCBI Gene 415130], NCOA2 (nuclear receptor coactivator 2) [NCBI Gene 10499] {aka GRIP1, KAT13C, NCoA-2, SRC-2, SRC2, TIF2}, NCOA1 (nuclear receptor coactivator 1) [NCBI Gene 8648] {aka F-SRC-1, KAT13A, RIP160, SRC1, bHLHe42, bHLHe74}, KMT2D (lysine methyltransferase 2D) [NCBI Gene 486558] {aka MLL2}, NCOA2 (nuclear receptor coactivator 2) [NCBI Gene 508162], NCOA1 (nuclear receptor coactivator 1) [NCBI Gene 525346], RB1 (RB transcriptional corepressor 1) [NCBI Gene 476915], STAT6 (signal transducer and activator of transcription 6) [NCBI Gene 100142679], MUC4 (mucin 4, cell surface associated) [NCBI Gene 488024], DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, PRRX1 (paired related homeobox 1) [NCBI Gene 540901], KMT2A (lysine methyltransferase 2A) [NCBI Gene 4297] {aka ALL-1, ALL1, CXXC7, GAS7, HRX, HTRX}, PRRX1 (paired related homeobox 1) [NCBI Gene 609105], KMT2D (lysine methyltransferase 2D) [NCBI Gene 506805] {aka MLL2}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 483021]
- **Diseases:** pleural effusion (MESH:D010996), lymphadenopathy (MESH:D008206), fatty liver (MESH:D005234), mesenchymal tumors (MESH:C535700), chest pain (MESH:D002637), myelodysplastic syndromes (MESH:D009190), fibromyxoid sarcoma (MESH:D012509), thoracic mass (MESH:C536030), coronary artery stenosis (MESH:D023921), Fusion (MESH:D000069337), mesenchymal neoplasm (MESH:D009369), calcification (MESH:D002114), rearranged (MESH:D002869), dyspnea (MESH:D004417), SEF (MESH:D005354), mediastinal myxoid spindle cell tumors (MESH:D002277), schwannoma (MESH:D009442), musculoskeletal developmental disorders (MESH:D009140), lymphomas (MESH:D008223), thymoma (MESH:D013945), LGFMS (MESH:D036821), necrosis (MESH:D009336), angiofibroma (MESH:D018322), leukemia (MESH:D007938), deficient (MESH:D007153), deleted (MESH:D002872), soft tissue tumors (MESH:D012983), teratoma (MESH:D013724), cough (MESH:D003371)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967484/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967484/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967484/full.md

---
Source: https://tomesphere.com/paper/PMC12967484